Kyung Dong Pharmaceutical Co (XKRX:011040) Interest Expense : ₩-1,556 Mil (TTM As of Mar. 2024)

View and export this data going back to 1992. Start your Free Trial

What is Kyung Dong Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Kyung Dong Pharmaceutical Co's interest expense for the three months ended in Mar. 2024 was ₩ -451 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,556 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Kyung Dong Pharmaceutical Co's Operating Income for the three months ended in Mar. 2024 was ₩ -768 Mil. Kyung Dong Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ₩ -451 Mil. Kyung Dong Pharmaceutical Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kyung Dong Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Kyung Dong Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyung Dong Pharmaceutical Co Interest Expense Chart

Kyung Dong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-465.60

-1,233.96

-65.82

-867.87

-1,596.37

Kyung Dong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-491.91	-1,014.88	-184.62	95.03	-451.15

Kyung Dong Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,556 Mil.

Kyung Dong Pharmaceutical Co (XKRX:011040) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kyung Dong Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ₩-451 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩-768 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₩15 Mil.

Kyung Dong Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Kyung Dong Pharmaceutical Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Kyung Dong Pharmaceutical Co (XKRX:011040) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyung Dong Pharmaceutical Co Ltd (XKRX:011040) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

1926, Nambusunhwan-ro, Gwanak-gu, Seoul, KOR

Website

http://www.kdpharma.co.kr

Kyung Dong Pharmaceutical Co Ltd is a South Korea-based company engaged in the manufacturing and marketing of pharmaceutical products. Its products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases.

Kyung Dong Pharmaceutical Co (XKRX:011040) Headlines

No Headlines